Arbovirus Testing Market Forecasts US$ 2.49 Billion by 2034

The global market for arbovirus testing (アルボウイルス検査市場) is expected to reach a value of US$ 1.43 billion by 2024, as per the latest market study by Fact.MR. It is projected that the demand for arbovirus testing worldwide will grow at a compound annual growth rate (CAGR) of 5.7%, reaching a market worth US$ 2.49 billion by 2034.

𝗚𝗲𝘁 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝗽𝘆:

https://www.factmr.com/connectus/sample?flag=S&rep_id=9182

The surge in arboviral diseases such as Zika, West Nile virus, chikungunya, and dengue among populations is anticipated to drive the need for accurate and efficient testing methods. Ongoing advancements in diagnostic technologies, such as ELISA, PCR, rapid testing kits, and nucleic acid amplification, are enhancing the specificity, sensitivity, and speed of arbovirus testing.

Government funding for research, coupled with initiatives and public health campaigns, is expected to focus on controlling and preventing the spread of arbovirus diseases, thus boosting the adoption of testing technologies. Additionally, the rise in global travel is contributing to the increased transmission of arboviral infections across regions, fueling the demand for test kits.

Growing awareness among both the general public and healthcare professionals regarding the symptoms, preventive measures, and risks associated with arboviral infections is driving the need for testing, prevention, and diagnosis.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗞𝗲𝘆 𝗗𝗿𝗶𝘃𝗲𝘀:

Increasing Incidence of Arboviral Infections: The rising incidence of arboviral diseases such as Zika virus, dengue fever, chikungunya, and West Nile virus among others has propelled the demand for arbovirus testing. As these diseases continue to spread globally, there is a growing need for accurate and timely diagnostic methods.

Technological Advancements in Testing Methods: Ongoing advancements in molecular diagnostics, serological testing, and nucleic acid amplification techniques have improved the sensitivity and specificity of arbovirus testing. These technological innovations have enabled faster and more accurate detection of arboviral infections, driving market growth.

Increasing Awareness and Government Initiatives: Heightened awareness among healthcare professionals and the general population regarding the risks associated with arboviral diseases has led to increased testing rates. Furthermore, government initiatives aimed at controlling the spread of these diseases and promoting early diagnosis have further stimulated market growth.

Globalization and Travel: The increasing globalization and travel contribute to the spread of arboviral diseases across regions. As individuals travel to and from endemic areas, there is a higher likelihood of introducing these infections to new locations, driving the demand for arbovirus testing in both travel medicine and public health sectors.

Surveillance Programs and Outbreak Preparedness: Governments and public health agencies worldwide are investing in surveillance programs to monitor and track the prevalence of arboviral diseases. These programs aid in early detection of outbreaks and help implement timely control measures, thereby driving the demand for arbovirus testing products and services.

𝗙𝘂𝘁𝘂𝗿𝗲 𝗢𝘂𝘁𝗹𝗼𝗼𝗸:

The future outlook for the arbovirus testing market (Marché des tests d'arbovirus) remains promising, with several factors poised to influence its growth trajectory:

Continued Research and Development: Ongoing research and development efforts aimed at developing novel testing methods, including point-of-care diagnostics and multiplex assays, are expected to expand the capabilities of arbovirus testing. These advancements will likely drive market penetration and adoption rates.

Expansion of End-user Base: The increasing adoption of arbovirus testing beyond traditional healthcare settings, including research laboratories, blood banks, and veterinary clinics, is anticipated to broaden the market's scope. Additionally, the incorporation of arbovirus testing into routine screening protocols in endemic regions will contribute to market expansion.

Emerging Markets: Emerging markets, particularly in Asia-Pacific, Latin America, and Africa, present significant growth opportunities for arbovirus testing due to the high burden of arboviral diseases in these regions. Government initiatives aimed at strengthening healthcare infrastructure and improving disease surveillance are expected to drive market growth in these areas.

Pandemic Preparedness: The lessons learned from recent pandemics such as Zika and COVID-19 have underscored the importance of preparedness and rapid response to emerging infectious diseases. Arbovirus testing will play a critical role in future pandemic preparedness efforts, leading to sustained demand for testing products and services.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀:

Agilent Technologies Inc.
NovaTec Immundiagnostica GmbH
Thermo Fisher Scientific
Euroeimmun AG
Abbot Laboratories
Bio-Rad
DiaSorin SpA
Fluke Biomedical
Distek
Copley Scientific
Becton
Distek
Dickinson and Company
Hoffmann La Roche Ltd.
Merck kGaA F
QIAGEN N.V.
Siemens Healthineers AG

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲:

Key players in the arbovirus testing tools market are employing various tactics to achieve their objectives, such as optimizing supply chain management, upholding product quality control, and fostering innovation. These companies are embracing diverse growth strategies, including introducing new products and forging partnerships, to enhance their competitive position.

For example,

Mylab unveiled the PathoDetect Extended Monsoon Fever Panel in July 2022. This advanced RT-PCR test kit is designed to effectively diagnose monsoon-related illnesses like dengue, malaria, and Zika. Offering swift and precise results within two hours, this innovative kit also boasts a mass testing capability, catering to the evolving needs of healthcare providers and patients alike.

𝗥𝗲𝗮𝗱 𝗠𝗼𝗿𝗲: https://www.factmr.com/report/arbovirus-testing-market

𝗠𝗮𝗿𝗸𝗲𝘁 𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

By Test Type :
ELISA-based Tests
RT-PCR Tests

By End User :
Hospitals
Public Health Laboratories
Diagnostic Centers

By Region :
North America
Europe
East Asia
Latin America
Middle East & Africa
South Asia & Oceania

𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗠𝗼𝗿𝗲 𝗥𝗲𝗹𝗮𝘁𝗲𝗱 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 𝗣𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗯𝘆 𝗙𝗮𝗰𝘁.𝗠𝗥 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵:

Preimplantation Genetic Testing Market (着床前遺伝子検査市場):

https://www.factmr.com/report/292/preimplantation-genetic-testing-market

Model Based Testing Market (モデルベースのテスト市場):

https://www.factmr.com/report/445/model-based-testing-market

Nipah Virus Testing Market (ニパウイルス検査市場):

https://www.factmr.com/report/865/nipah-virus-testing-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.